Hem Crysotiles Private Limited - Company Profile

It is a metals and minerals private limited company based in Mumbai, Maharashtra, India, established in 1997.

1997 Mumbai, Maharashtra, India Struck Off

Last Updated: July 21, 2025

About Hem Crysotiles Private Limited

Hem Crysotiles Private Limited, a struck off private limited company, was established on 07 March 1997 in Mumbai, Maharashtra, India. Engaging in construction materials retail & distribution within the trade sector, it holds CIN: U26990MH1997PTC106418. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.21 M.

It upholds a active non-compliant status. Its leadership includes Ganesh Sharad Kelkar (Additional Director), Bhushan Raghunath Mali (Additional Director). Past directors included Sangeeta Vinod Motwani, Sunita Raja Hemwani, Raja Hemwani. Its latest AGM occurred on 30 September 2016, with the balance sheet filed on 31 March 2016. It is based at Flat No 1, 2Nd Floor, H M Tower Bandra (W) Junction Of 24Th & 29 Th Road, Mumbai, Maharashtra, 400050.

Company Details

CIN/LLPIN
U26990MH1997PTC106418
Registration Number
106418
Incorporation Date
07 March 1997
Authorized Capital
₹2.50 M
Paid-Up Capital
₹0.21 M
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Struck Off

Key Metrics

Authorised Capital ₹ 2.50 M as on 21-07-2025
Paid Up Capital ₹ 0.21 M as on 21-07-2025
Company Age 28 Year, 11 Months
Last Filing with ROC 31 Mar 2016
Revenue Growth **** 71842.87% (FY 2016)
Profit Growth **** 11420.49% (FY 2016)
Ebitda **** 925.38% (FY 2016)
Net Worth 13.34% (FY 2016)
Total Assets **** 2154.08% (FY 2016)

Comprehensive Company Insights

Explore comprehensive insights into Hem Crysotiles Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Hem Crysotiles Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Ganesh Sharad Kelkar	Additional Director	26 Nov 2018	Current
Bhushan Raghunath Mali	Additional Director	22 Feb 2018	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	30 Nov 2018	Past
Pramod Abcsdd	Additional Director	01 Dec 2016	Past
Pramod Abcsdd	Director	01 Dec 2016	Past
Pramod Abcsdd	Director	28 Feb 2017	Past
Pramod Abcsdd	Director	18 Nov 2014	Past
Pramod Abcsdd	Additional Director	30 Nov 2018	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hem Crysotiles.

Hem Crysotiles Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 71842.87% increase. The company also saw a substantial improvement in profitability, with a 11420.49% increase in profit. The company's net worth Soared by an impressive increase of 13.34%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

71842.87%

*******

Revenue from Operations

*******

Total Assets

*******

2154.08%

*******

Profit or Loss

*******

11420.49%

*******

Net Worth

*******

13.34%

*******

EBITDA

*******

925.38%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hem Crysotiles?

In 2016, Hem Crysotiles had a promoter holding of 98.83% and a public holding of 1.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Hem Crysotiles?

Unlock and access historical data on people associated with Hem Crysotiles, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Hem Crysotiles, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hem Crysotiles's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hem Crysotiles

Recent Activity within the Organization

Director Appointment

The activity Ganesh Sharad Kelkar was appointed as a Additional Director was appointed as a Additional Director on 26 Nov 2018 & has been associated with this company since 7 years 3 months . was completed.
26 Nov 2018
Director Appointment

Bhushan Raghunath Mali was appointed as a Additional Director was appointed as a Additional Director on 22 Feb 2018 & has been associated with this company since 8 years 11 days . was recorded as a recent event.
22 Feb 2018
Annual General Meeting

Hem Crysotiles Private Limited last Annual general meeting of members was held on 30 Sep 2016 as per latest MCA records. was recorded as a recent event.
30 Sep 2016
Balance Sheet

Hem Crysotiles Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Mumbai. was recorded as a recent event.
31 Mar 2016
Company Incorporation

Progress on Hem Crysotiles Private Limited was registered on 07 Mar 1997 with Roc Mumbai & aged 28 years 11 months as per MCA records. was documented.
07 Mar 1997

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Hem Crysotiles Private Limited?

The CIN of Hem Crysotiles Private Limited is U26990MH1997PTC106418.

Where is Hem Crysotiles Private Limited headquartered?

Hem Crysotiles Private Limited is headquartered at Flat No 1, 2Nd Floor, H M Tower Bandra (W) Junction Of 24Th & 29 Th Road, Mumbai, Maharashtra, 400050.

When was Hem Crysotiles Private Limited incorporated?

Hem Crysotiles Private Limited was incorporated on 07 March 1997.

Who are the current directors of Hem Crysotiles Private Limited?

The current directors of Hem Crysotiles Private Limited are

What is the primary industry of Hem Crysotiles Private Limited?

The primary industry of Hem Crysotiles Private Limited is Trade.

Is Hem Crysotiles Private Limited a listed company?

Hem Crysotiles Private Limited is unlisted.

What is the capital structure of Hem Crysotiles Private Limited?

The authorized capital of Hem Crysotiles Private Limited is ₹2.50 M, and the paid-up capital is ₹0.21 M.

What is the compliance status of Hem Crysotiles Private Limited?

The compliance status of Hem Crysotiles Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available